The iShares NASDAQ Biotechnology Index ended the five days ended Friday, June 23 up 26% to close at $370.74.
Time for this one to pop.
Don't go into this weekend unprepared.
Merck is extending this week's impressive rally and will soon retest the 2017 highs.
What Cigna's David Cordani had to say at a new investor day.
Biotechs are hot.
Morgan Stanley analyst David Risinger argued for the drugmaker to part ways with its consumer health division.